{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:38:27Z","timestamp":1787841507879,"version":"build-2784847793"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05975-4","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:21:35Z","timestamp":1756812095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular risk in axial spondyloarthritis: the interplay of inflammation, traditional risk factors, and management strategies"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6980-7708","authenticated-orcid":false,"given":"\u0410inur","family":"Issakulova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-6918","authenticated-orcid":false,"given":"Marlen","family":"Yessirkepov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6065-8002","authenticated-orcid":false,"given":"Burhan Fatih","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"5975_CR1","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00296-024-05601-9","volume":"44","author":"M Ivanova","year":"2024","unstructured":"Ivanova M, Zimba O, Dimitrov I, Angelov AK, Georgiev T (2024) Axial spondyloarthritis: an overview of the disease. Rheumatol Int 44:1607\u20131619. https:\/\/doi.org\/10.1007\/s00296-024-05601-9","journal-title":"Rheumatol Int"},{"key":"5975_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00296-023-05523-y","volume":"44","author":"MT Duru\u00f6z","year":"2024","unstructured":"Duru\u00f6z MT, Bodur H, Ataman \u015e et al (2024) Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: real-life evidence from BIOSTAR nationwide registry. Rheumatol Int 44:631\u2013642. https:\/\/doi.org\/10.1007\/s00296-023-05523-y","journal-title":"Rheumatol Int"},{"key":"5975_CR3","doi-asserted-by":"publisher","first-page":"152037","DOI":"10.1016\/j.semarthrit.2022.152037","volume":"55","author":"J Rueda-Gotor","year":"2022","unstructured":"Rueda-Gotor J, Ferraz-Amaro I, Genre F et al (2022) Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis: a multicenter study on 838 patients. Semin Arthritis Rheum 55:152037. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152037","journal-title":"Semin Arthritis Rheum"},{"key":"5975_CR4","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167\u20132172","journal-title":"J Rheumatol"},{"key":"5975_CR5","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/art.30581","volume":"63","author":"SM Szabo","year":"2011","unstructured":"Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, Maksymowych WP (2011) Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 63:3294\u20133304. https:\/\/doi.org\/10.1002\/art.30581","journal-title":"Arthritis Rheum"},{"key":"5975_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","volume":"19","author":"K Bengtsson","year":"2017","unstructured":"Bengtsson K, Forsblad-d\u2019Elia H, Lie E et al (2017) Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther 19:102. https:\/\/doi.org\/10.1186\/s13075-017-1315-z","journal-title":"Arthritis Res Ther"},{"key":"5975_CR7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.semarthrit.2014.10.007","volume":"44","author":"S Mathieu","year":"2015","unstructured":"Mathieu S, Pereira B, Soubrier M (2015) Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum 44:551\u2013555. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.10.007","journal-title":"Semin Arthritis Rheum"},{"key":"5975_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/acr.24820","volume":"75","author":"H Chaudhary","year":"2023","unstructured":"Chaudhary H, Bohra N, Syed K, Donato A, Murad MH, Karmacharya P (2023) All-cause and cause-specific mortality in psoriatic arthritis and ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 75:1052\u20131065. https:\/\/doi.org\/10.1002\/acr.24820","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5975_CR9","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2011.151191","volume":"70","author":"G Bakland","year":"2011","unstructured":"Bakland G, Gran JT, Nossent JC (2011) Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 70:1921\u20131925. https:\/\/doi.org\/10.1136\/ard.2011.151191","journal-title":"Ann Rheum Dis"},{"key":"5975_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1756-185X.13970","volume":"24","author":"JH Kim","year":"2021","unstructured":"Kim JH, Choi IA (2021) Cardiovascular morbidity and mortality in patients with spondyloarthritis: a meta-analysis. Int J Rheum Dis 24:477\u2013486. https:\/\/doi.org\/10.1111\/1756-185X.13970","journal-title":"Int J Rheum Dis"},{"key":"5975_CR11","doi-asserted-by":"publisher","first-page":"1759720X2211224","DOI":"10.1177\/1759720X221122401","volume":"14","author":"LH Shi","year":"2022","unstructured":"Shi LH, Lam SH, So H, Li EK, Li TK, Szeto CC, Tam LS (2022) High inflammatory burden predicts cardiovascular events in patients with axial spondyloarthritis: a long-term follow-up study. Ther Adv Musculoskelet Dis 14:1759720X221122401. https:\/\/doi.org\/10.1177\/1759720X221122401","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5975_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","volume":"74","author":"EE Arts","year":"2015","unstructured":"Arts EE, Popa C, Den Broeder AA et al (2015) Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann Rheum Dis 74:668\u2013674. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204024","journal-title":"Ann Rheum Dis"},{"key":"5975_CR13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/annrheumdis-2016-209233","volume":"75","author":"A Baillet","year":"2016","unstructured":"Baillet A, Gossec L, Carmona L et al (2016) Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 75:965\u2013973. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209233","journal-title":"Ann Rheum Dis"},{"key":"5975_CR14","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1007\/s00296-024-05740-z","volume":"44","author":"Z Gu\u0142a","year":"2024","unstructured":"Gu\u0142a Z, \u0141osi\u0144ska K, Kuszmiersz P et al (2024) A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort. Rheumatol Int 44:2817\u20132828. https:\/\/doi.org\/10.1007\/s00296-024-05740-z","journal-title":"Rheumatol Int"},{"key":"5975_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5975_CR16","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s10067-023-06655-z","volume":"42","author":"R Hintenberger","year":"2023","unstructured":"Hintenberger R, Affenzeller B, Vladychuk V, Pieringer H (2023) Cardiovascular risk in axial spondyloarthritis\u2014a systematic review. Clin Rheumatol 42:2621\u20132633. https:\/\/doi.org\/10.1007\/s10067-023-06655-z","journal-title":"Clin Rheumatol"},{"key":"5975_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.semarthrit.2021.02.003","volume":"51","author":"I Gonz\u00e1lez Maz\u00f3n","year":"2021","unstructured":"Gonz\u00e1lez Maz\u00f3n I, Rueda-Gotor J, Ferraz-Amaro I et al (2021) Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis: a multicenter study on 806 patients. Semin Arthritis Rheum 51:395\u2013403. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.02.003","journal-title":"Semin Arthritis Rheum"},{"key":"5975_CR18","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1038\/s41598-022-11640-8","volume":"12","author":"L Navarini","year":"2022","unstructured":"Navarini L, Currado D, Marino A et al (2022) Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis. Sci Rep 12:7498. https:\/\/doi.org\/10.1038\/s41598-022-11640-8","journal-title":"Sci Rep"},{"key":"5975_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/BMR-220141","volume":"36","author":"BT Aicha","year":"2023","unstructured":"Aicha BT, Ahmed F, Seif B et al (2023) Spinal radiographic progression is correlated with preclinical atherosclerosis in spondyloarthritis. J Back Musculoskelet Rehabil 36:701\u2013708. https:\/\/doi.org\/10.3233\/BMR-220141","journal-title":"J Back Musculoskelet Rehabil"},{"key":"5975_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.20452\/pamw.4300","volume":"128","author":"P Ozdowska","year":"2018","unstructured":"Ozdowska P, Wardziak \u0141, Kruk M et al (2018) Increased prevalence of subclinical coronary atherosclerosis in young patients with ankylosing spondylitis. Pol Arch Intern Med 128:455\u2013461. https:\/\/doi.org\/10.20452\/pamw.4300","journal-title":"Pol Arch Intern Med"},{"key":"5975_CR21","doi-asserted-by":"publisher","first-page":"e004187","DOI":"10.1136\/rmdopen-2024-004187","volume":"10","author":"I Ferraz-Amaro","year":"2024","unstructured":"Ferraz-Amaro I, Genre F, Blanco R et al (2024) Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis: a multicentre study of 913 patients. RMD Open 10:e004187. https:\/\/doi.org\/10.1136\/rmdopen-2024-004187","journal-title":"RMD Open"},{"key":"5975_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.arteri.2022.03.005","volume":"34","author":"M Slouma","year":"2022","unstructured":"Slouma M, Ben Ali K, Kharrat L, Zouaoui C, Ouertani H, Gharsallah I (2022) Athrogenic indexes: useful markers for predicting metabolic syndrome in axial spondyloarthritis. Clin Investig Arterioscler 34:261\u2013268. https:\/\/doi.org\/10.1016\/j.arteri.2022.03.005","journal-title":"Clin Investig Arterioscler"},{"key":"5975_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5114\/reum.2021.110610","volume":"59","author":"P Ozdowska","year":"2021","unstructured":"Ozdowska P, Kowalik I, Sadowski K et al (2021) Patterns of dyslipidemia in young patients with seronegative spondyloarthropathies without cardiovascular diseases. Reumatologia 59:285\u2013291. https:\/\/doi.org\/10.5114\/reum.2021.110610","journal-title":"Reumatologia"},{"key":"5975_CR24","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.55563\/clinexprheumatol\/gtcard","volume":"41","author":"AT Masi","year":"2023","unstructured":"Masi AT, Fessler SL, Brezka ML, Wang Y, Donohue SE (2023) Systematic review and meta-analysis of individual serum lipids and analysis of lipid ratios in ankylosing spondylitis and healthy control cohorts: significantly lower mean HDL-cholesterol level in ankylosing spondylitis cohorts. Clin Exp Rheumatol 41:1862\u20131874. https:\/\/doi.org\/10.55563\/clinexprheumatol\/gtcard","journal-title":"Clin Exp Rheumatol"},{"key":"5975_CR25","doi-asserted-by":"publisher","first-page":"300060525131394","DOI":"10.1177\/03000605251313949","volume":"53","author":"C Remus","year":"2025","unstructured":"Remus C, Hoffmeister M, Strathmeyer S et al (2025) Dysregulation of amino acid and lipid metabolism in patients with spondyloarthritis. J Int Med Res 53:3000605251313949. https:\/\/doi.org\/10.1177\/03000605251313949","journal-title":"J Int Med Res"},{"key":"5975_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/000331978803900702","volume":"39","author":"MG Alves","year":"1988","unstructured":"Alves MG, Espirito-Santo J, Queiroz MV, Madeira H, Macieira-Coelho E (1988) Cardiac alterations in ankylosing spondylitis. Angiology 39:567\u2013571. https:\/\/doi.org\/10.1177\/000331978803900702","journal-title":"Angiology"},{"key":"5975_CR27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","volume":"75","author":"A Molt\u00f3","year":"2016","unstructured":"Molt\u00f3 A, Etcheto A, van der Heijde D et al (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75:1016\u20131023. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208174","journal-title":"Ann Rheum Dis"},{"key":"5975_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.46497\/ArchRheumatol.2023.9793","volume":"38","author":"HF \u00c7ay","year":"2022","unstructured":"\u00c7ay HF, Alkan Meliko\u011flu M, Yurdakul FG et al (2022) Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar. Arch Rheumatol 38:333\u2013346. https:\/\/doi.org\/10.46497\/ArchRheumatol.2023.9793","journal-title":"Arch Rheumatol"},{"key":"5975_CR29","doi-asserted-by":"publisher","first-page":"2205056","DOI":"10.1080\/10641963.2023.2205056","volume":"45","author":"LH Shi","year":"2023","unstructured":"Shi LH, Lam SH, So H, Chan CY, Li TK, Szeto CC, Tam LS (2023) Inflammation is associated with incident hypertension in patients with axial spondyloarthritis: a longitudinal cohort study. Clin Exp Hypertens 45:2205056. https:\/\/doi.org\/10.1080\/10641963.2023.2205056","journal-title":"Clin Exp Hypertens"},{"key":"5975_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrcardio.2017.118","volume":"15","author":"E Bartoloni","year":"2018","unstructured":"Bartoloni E, Alunno A, Gerli R (2018) Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol 15:33\u201344. https:\/\/doi.org\/10.1038\/nrcardio.2017.118","journal-title":"Nat Rev Cardiol"},{"key":"5975_CR31","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00296-024-05700-7","volume":"44","author":"L Gumber","year":"2024","unstructured":"Gumber L, Samarasinghe H, Gladston P, Moorthy A (2024) Diabetes in axial spondyloarthritis: a systematic review and meta-analysis of observational studies. Rheumatol Int 44:2381\u20132388. https:\/\/doi.org\/10.1007\/s00296-024-05700-7","journal-title":"Rheumatol Int"},{"key":"5975_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3899\/jrheum.150648","volume":"43","author":"F Maas","year":"2016","unstructured":"Maas F, Arends S, van der Veer E et al (2016) Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome. J Rheumatol 43:383\u2013387. https:\/\/doi.org\/10.3899\/jrheum.150648","journal-title":"J Rheumatol"},{"key":"5975_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/1756-185X.13912","volume":"23","author":"CH Chen","year":"2020","unstructured":"Chen CH, Chen HA, Liu CH, Liao HT, Chou CT, Chen CH (2020) Association of obesity with inflammation, disease severity and cardiovascular risk factors among patients with ankylosing spondylitis. Int J Rheum Dis 23:1165\u20131174. https:\/\/doi.org\/10.1111\/1756-185X.13912","journal-title":"Int J Rheum Dis"},{"key":"5975_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","volume":"382","author":"N Bhala","year":"2013","unstructured":"Bhala N, Emberson J, Merhi A et al (2013) Vascular and upper Gastrointestinal effects of nonsteroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382:769\u2013779. https:\/\/doi.org\/10.1016\/S0140-6736(13)60900-9","journal-title":"Lancet"},{"key":"5975_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N (2015) Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 163:409\u2013416. https:\/\/doi.org\/10.7326\/M14-2470","journal-title":"Ann Intern Med"},{"key":"5975_CR36","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1093\/rheumatology\/kead072","volume":"62","author":"O Fakih","year":"2023","unstructured":"Fakih O, Desmarets M, Martin B, Prati C, Wendling D, Monnet E, Verhoeven F (2023) Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study. Rheumatology (Oxford) 62:3317\u20133322. https:\/\/doi.org\/10.1093\/rheumatology\/kead072","journal-title":"Rheumatology (Oxford)"},{"key":"5975_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/ard-2023-225406","volume":"83","author":"JW Kim","year":"2024","unstructured":"Kim JW, Yoon JS, Park S, Kim H, Lee JS, Choe JY (2024) Risk of cardiovascular disease with high-dose versus low-dose use of nonsteroidal anti-inflammatory drugs in ankylosing spondylitis. Ann Rheum Dis 83:1028\u20131033. https:\/\/doi.org\/10.1136\/ard-2023-225406","journal-title":"Ann Rheum Dis"},{"key":"5975_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/09733698251328076","author":"R Malik","year":"2025","unstructured":"Malik R, Malaviya AN (2025) Continuous nonsteroidal anti-inflammatory drugs for the treatment of axial spondyloarthritis and cardiovascular disease: harmful, protective or neutral? Indian J Rheumatol. https:\/\/doi.org\/10.1177\/09733698251328076","journal-title":"Indian J Rheumatol"},{"key":"5975_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/annrheumdis-2013-203934","volume":"74","author":"AM van Sijl","year":"2015","unstructured":"van Sijl AM, van Eijk IC, Peters MJ et al (2015) Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis. Ann Rheum Dis 74:119\u2013123. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203934","journal-title":"Ann Rheum Dis"},{"key":"5975_CR40","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00296-015-3314-1","volume":"35","author":"F Genre","year":"2015","unstructured":"Genre F, L\u00f3pez-Mej\u00edas R, Miranda-Filloy JA et al (2015) Anti-TNF-\u03b1 therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients. Rheumatol Int 35:2069\u20132078. https:\/\/doi.org\/10.1007\/s00296-015-3314-1","journal-title":"Rheumatol Int"},{"key":"5975_CR41","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/rheumatology\/ket454","volume":"53","author":"LS Tam","year":"2014","unstructured":"Tam LS, Kitas GD, Gonz\u00e1lez-Gay MA (2014) Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) 53:1108\u20131119. https:\/\/doi.org\/10.1093\/rheumatology\/ket454","journal-title":"Rheumatology (Oxford)"},{"key":"5975_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-024-03405-7","volume":"26","author":"OC Kwon","year":"2024","unstructured":"Kwon OC, Lee HS, Jeon SY, Park MC (2024) Incidence rate of recurrent cardiovascular events in patients with radiographic axial spondyloarthritis and the effect of tumor necrosis factor inhibitors. Arthritis Res Ther 26:174. https:\/\/doi.org\/10.1186\/s13075-024-03405-7","journal-title":"Arthritis Res Ther"},{"key":"5975_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10067-024-07225-7","volume":"44","author":"OC Kwon","year":"2025","unstructured":"Kwon OC, Lee HS, Yang J, Park MC (2025) Cardiovascular risk according to biological agent exposure in patients with ankylosing spondylitis: a nationwide population-based study. Clin Rheumatol 44:257\u2013266. https:\/\/doi.org\/10.1007\/s10067-024-07225-7","journal-title":"Clin Rheumatol"},{"key":"5975_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","volume":"16","author":"M Robert","year":"2017","unstructured":"Robert M, Miossec P (2017) Effects of Interleukin 17 on the cardiovascular system. Autoimmun Rev 16:984\u2013991. https:\/\/doi.org\/10.1016\/j.autrev.2017.07.009","journal-title":"Autoimmun Rev"},{"key":"5975_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/annrheumdis-2019-216118","volume":"79","author":"M Dougados","year":"2020","unstructured":"Dougados M, Wei JC, Landew\u00e9 R et al (2020) Efficacy and safety of Ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Ann Rheum Dis 79:176\u2013185. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216118","journal-title":"Ann Rheum Dis"},{"key":"5975_CR46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40744-022-00434-z","volume":"9","author":"JF Merola","year":"2022","unstructured":"Merola JF, McInnes IB, Deodhar AA et al (2022) Effect of Secukinumab on traditional cardiovascular risk factors and inflammatory biomarkers: post hoc analyses of pooled data across three indications. Rheumatol Ther 9:935\u2013955. https:\/\/doi.org\/10.1007\/s40744-022-00434-z","journal-title":"Rheumatol Ther"},{"key":"5975_CR47","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.clinthera.2025.01.005","volume":"47","author":"SS Zhao","year":"2025","unstructured":"Zhao SS, Riley D, Hernandez G, Alam U (2025) Comparative safety of JAK inhibitors versus TNF or IL-17 inhibitors for cardiovascular disease and cancer in psoriatic arthritis and axial spondyloarthritis. Clin Ther 47:293\u2013297. https:\/\/doi.org\/10.1016\/j.clinthera.2025.01.005","journal-title":"Clin Ther"},{"key":"5975_CR48","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/S0140-6736(19)32534-6","volume":"394","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Song IH, Pangan AL et al (2019) Efficacy and safety of Upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2\/3 trial. Lancet 394:2108\u20132117. https:\/\/doi.org\/10.1016\/S0140-6736(19)32534-6","journal-title":"Lancet"},{"key":"5975_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0140-6736(22)01212-0","volume":"400","author":"A Deodhar","year":"2022","unstructured":"Deodhar A, Van den Bosch F, Poddubnyy D et al (2022) Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 400:369\u2013379. https:\/\/doi.org\/10.1016\/S0140-6736(22)01212-0","journal-title":"Lancet"},{"key":"5975_CR50","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.3390\/jcm11236894","volume":"11","author":"A Makris","year":"2022","unstructured":"Makris A, Barkas F, Sfikakis PP, Liberopoulos E, Agouridis AP (2022) The effect of Upadacitinib on lipid profile and cardiovascular events: a meta-analysis of randomized controlled trials. J Clin Med 11:6894. https:\/\/doi.org\/10.3390\/jcm11236894","journal-title":"J Clin Med"},{"key":"5975_CR51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR et al (2022) Cardiovascular and cancer risk with Tofacitinib in rheumatoid arthritis. N Engl J Med 386:316\u2013326. https:\/\/doi.org\/10.1056\/NEJMoa2109927","journal-title":"N Engl J Med"},{"key":"5975_CR52","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00296-019-04494-3","volume":"40","author":"EH Coulter","year":"2020","unstructured":"Coulter EH, McDonald MT, Cameron S, Siebert S, Paul L (2020) Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis. Rheumatol Int 40:375\u2013381. https:\/\/doi.org\/10.1007\/s00296-019-04494-3","journal-title":"Rheumatol Int"},{"key":"5975_CR53","doi-asserted-by":"publisher","first-page":"105873","DOI":"10.1016\/j.jbspin.2025.105873","volume":"92","author":"D Kiefer","year":"2025","unstructured":"Kiefer D, Braun J, Kiltz U et al (2025) Prevalence and associations of kinesiophobia with patient reported outcomes and mobility measures in axial spondyloarthritis. Joint Bone Spine 92:105873. https:\/\/doi.org\/10.1016\/j.jbspin.2025.105873","journal-title":"Joint Bone Spine"},{"key":"5975_CR54","doi-asserted-by":"publisher","first-page":"e108688","DOI":"10.1371\/journal.pone.0108688","volume":"9","author":"SH Sveaas","year":"2014","unstructured":"Sveaas SH, Berg IJ, Provan SA et al (2014) Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study. PLoS ONE 9:e108688. https:\/\/doi.org\/10.1371\/journal.pone.0108688","journal-title":"PLoS ONE"},{"key":"5975_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13075-021-02600-0","volume":"23","author":"F Ometto","year":"2021","unstructured":"Ometto F, Ortolan A, Farber D et al (2021) Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort. Arthritis Res Ther 23:219. https:\/\/doi.org\/10.1186\/s13075-021-02600-0","journal-title":"Arthritis Res Ther"},{"key":"5975_CR56","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.3390\/nu14224730","volume":"14","author":"P Vergne-Salle","year":"2022","unstructured":"Vergne-Salle P, Salle L, Fressinaud-Marie AC et al (2022) Diet and disease activity in patients with axial spondyloarthritis: spondyloarthritis and nutrition study (SANUT). Nutrients 14:4730. https:\/\/doi.org\/10.3390\/nu14224730","journal-title":"Nutrients"},{"key":"5975_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00296-016-3590-4","volume":"37","author":"S Zhao","year":"2017","unstructured":"Zhao S, Challoner B, Khattak M, Moots RJ, Goodson NJ (2017) Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. Rheumatol Int 37:239\u2013244. https:\/\/doi.org\/10.1007\/s00296-016-3590-4","journal-title":"Rheumatol Int"},{"key":"5975_CR58","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00296-004-0451-3","volume":"25","author":"U Kaan","year":"2005","unstructured":"Kaan U, Ferda O (2005) Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int 25:357\u2013360. https:\/\/doi.org\/10.1007\/s00296-004-0451-3","journal-title":"Rheumatol Int"},{"key":"5975_CR59","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00296-015-3381-3","volume":"35","author":"GT Sakellariou","year":"2015","unstructured":"Sakellariou GT, Anastasilakis AD, Kenanidis E et al (2015) The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis. Rheumatol Int 35:2109\u20132114. https:\/\/doi.org\/10.1007\/s00296-015-3381-3","journal-title":"Rheumatol Int"},{"key":"5975_CR60","doi-asserted-by":"publisher","first-page":"105059","DOI":"10.1016\/j.jbspin.2020.07.008","volume":"88","author":"C Giraud","year":"2021","unstructured":"Giraud C, Lambert C, Dutheil F, Pereira B, Soubrier M, Tournadre A (2021) The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis. Joint Bone Spine 88:105059. https:\/\/doi.org\/10.1016\/j.jbspin.2020.07.008","journal-title":"Joint Bone Spine"},{"key":"5975_CR61","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjsports-2018-099943","volume":"54","author":"SH Sveaas","year":"2020","unstructured":"Sveaas SH, Bilberg A, Berg IJ et al (2020) High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. Br J Sports Med 54:292\u2013297. https:\/\/doi.org\/10.1136\/bjsports-2018-099943","journal-title":"Br J Sports Med"},{"key":"5975_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00296-014-3141-9","volume":"35","author":"T O\u2019Dwyer","year":"2015","unstructured":"O\u2019Dwyer T, O\u2019Shea F, Wilson F (2015) Physical activity in spondyloarthritis: a systematic review. Rheumatol Int 35:393\u2013404. https:\/\/doi.org\/10.1007\/s00296-014-3141-9","journal-title":"Rheumatol Int"},{"key":"5975_CR63","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s00296-024-05738-7","volume":"44","author":"Y Fedorchenko","year":"2024","unstructured":"Fedorchenko Y, Zimba O, Sagtaganov Z, Yessirkepov M (2024) Enhancing chronic disease management through physical activity and pedometry-based health monitoring. Rheumatol Int 44:2737\u20132743. https:\/\/doi.org\/10.1007\/s00296-024-05738-7","journal-title":"Rheumatol Int"},{"key":"5975_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00296-024-05755-6","volume":"45","author":"AW de Leeuw","year":"2025","unstructured":"de Leeuw AW, van Wissen MAT, Vlieland TPMV et al (2025) Personalized physical activity recommendations for people with axial spondyloarthritis using wearable activity tracker data: an exploratory study. Rheumatol Int 45:65. https:\/\/doi.org\/10.1007\/s00296-024-05755-6","journal-title":"Rheumatol Int"},{"key":"5975_CR65","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13075-025-03575-y","volume":"27","author":"M Carbo","year":"2025","unstructured":"Carbo M, Hilberdink B, Paap D, Wink F, Vlieland TV, van Weely S, Spoorenberg A, Arends S (2025) Physical activity in relation to health status, quality of life and compliance with world health organization recommendations in patients with axial spondyloarthritis. Arthritis Res Ther 27:112. https:\/\/doi.org\/10.1186\/s13075-025-03575-y","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05975-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05975-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:15:27Z","timestamp":1760523327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05975-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["5975"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05975-4","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Since there are no human participants, there is no informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"214"}}